Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
---|---|---|---|---|
|
|
Health: Unknown
Source: patients with periodontitis
DNA G+C(%): 47
|
Opt. T: 30-37℃
Lower T(℃): 25(w)
High T(℃): 45(neg)
Bile reaction(%): 20(neg)
|
|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
---|---|---|---|---|
|
|
|
|
|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
---|---|---|---|---|
|
|
|
|
|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
---|---|---|---|---|
|
|
|
|
|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
---|---|---|---|---|
|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
---|---|---|---|---|
penicillin_G: Var(MIC50): 0.06, MIC90: 16, RNG: (≤0.015–32)
|
|
|
azithromycin: S(MIC50): 0.5, MIC90: 2, RNG: (0.25–2)
erythromycin: S(MIC50): 0.5, MIC90: 1, RNG: (0.125–1)
|
levofloxacin: S(MIC50): 0.25, MIC90: 0.5, RNG: (0.125–0.5)
moxifloxacin: S(MIC50): 0.125, MIC90: 0.5, RNG: (0.06–0.5)
|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
doxycycline: S(MIC50): 0.125, MIC90: 8, RNG: (0.06–8)
minocycline: S(MIC50): 0.06, MIC90: 8, RNG: (0.03–8)
tetracycline: Var(MIC50): 0.25, MIC90: 16, RNG: (0.125–16)
|
vancomycin: S(MIC50): 0.8, MIC90: 0.8, RNG: (0.8)
|
|
chloramphenicol: Sens
|
clindamycin: Sens
|